Stock Scorecard



Stock Summary for Resmed Inc (RMD) - $224.46 as of 8/14/2026 8:34:40 PM EST

Total Score

20 out of 30

Safety Score

68 out of 100

Currently on the following lists
Dividend Stock List
Tim's Recommendation
Buy

Growth List Algorithm Criteria for RMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RMD (68 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 7
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for RMD

ResMed Inc. stock falls Friday, underperforms market 8/14/2026 10:12:00 PM
How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds 8/14/2026 2:39:00 AM
RESMED INC. : RBC RAISES TARGET PRICE TO $244 FROM $234 8/14/2026 2:09:00 AM
ResMed Inc. Files Annual Form 10-K Report for Fiscal Year Ended June 30, 2026 8/13/2026 11:14:00 PM
RESMED INC FY 2026: Revenue $5.65B, EPS $10.43— 10-K Summary 8/13/2026 9:38:00 PM
How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds 8/13/2026 1:33:00 PM
Handelsbanken Fonder AB Raises Stock Position in ResMed Inc. $RMD 8/13/2026 10:11:00 AM
Insulet Corporation (PODD) Stock forecasts 8/13/2026 10:09:00 AM
Weekly Earnings Wrap: CBA, REA Group, Westpac, Resmed and more 8/13/2026 8:43:00 AM
ResMed Inc. Stock 12‑Month Price Target Cut to $258.47, Implies 14% Upside 8/13/2026 7:20:00 AM

Financial Details for RMD

Company Overview

Ticker RMD
Company Name Resmed Inc
Country USA
Description ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 6/30/2026
Next Earnings Date N/A

Stock Price History

Last Day Price 224.46
Price 4 Years Ago 201.29
Last Day Price Updated 8/14/2026 8:34:40 PM EST
Last Day Volume 1,192,818
Average Daily Volume 1,516,259
52-Week High 291.57
52-Week Low 180.27
Last Price to 52 Week Low 24.51%

Valuation Measures

Trailing PE 21.54
Industry PE 50.04
Sector PE 51.80
5-Year Average PE 27.25
Free Cash Flow Ratio 19.60
Industry Free Cash Flow Ratio 25.31
Sector Free Cash Flow Ratio 37.18
Current Ratio Most Recent Quarter 3.01
Total Cash Per Share 11.45
Book Value Per Share Most Recent Quarter 45.51
Price to Book Ratio 4.85
Industry Price to Book Ratio 6.10
Sector Price to Book Ratio 9.45
Price to Sales Ratio Twelve Trailing Months 5.80
Industry Price to Sales Ratio Twelve Trailing Months 165.07
Sector Price to Sales Ratio Twelve Trailing Months 32.37
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 145,056,000
Market Capitalization 32,559,269,760
Institutional Ownership 75.71%

Dividends

Ex-Dividend Date 8/20/2026
Previous Dividend Amount 0.6000
Current Dividend Amount 0.6600
Total Years Dividend Increasing Dividend Contender - Increasing for 14 Years
Trailing Annual Dividend Rate 2.40
Trailing Annual Dividend Yield 1.09%
Forward Annual Dividend Rate 2.64
Forward Annual Dividend Yield 1.20%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 0.94%
5-Year Average Dividend Yield 0.95%
1-Year Dividend Growth Rate Percentage 16.81%
3-Year Dividend Growth Rate Percentage 8.08%
5-Year Dividend Growth Rate Percentage 11.31%
All-Time Dividend Growth Rate Percentage 8.60%
Dividend Payout Ratio 22.16%

Income Statement

Quarterly Earnings Growth YOY 2.30%
Annual Earnings Growth 8.75%
Reported EPS 12 Trailing Months 10.49
Reported EPS Past Year 11.17
Reported EPS Prior Year 9.55
Net Income Twelve Trailing Months 1,523,293,000
Net Income Past Year 1,523,293,000
Net Income Prior Year 1,400,723,000
Quarterly Revenue Growth YOY 8.60%
5-Year Revenue Growth 12.08%
Operating Margin Twelve Trailing Months 31.00%

Balance Sheet

Total Cash Most Recent Quarter 1,660,513,000
Total Cash Past Year 1,209,450,000
Total Cash Prior Year 238,361,000
Net Cash Position Most Recent Quarter 1,256,345,000
Net Cash Position Past Year 551,058,000
Long Term Debt Past Year 658,392,000
Long Term Debt Prior Year 697,313,000
Total Debt Most Recent Quarter 404,168,000
Equity to Debt Ratio Past Year 0.90
Equity to Debt Ratio Most Recent Quarter 0.94
Total Stockholder Equity Past Year 5,967,859,000
Total Stockholder Equity Prior Year 4,864,043,000
Total Stockholder Equity Most Recent Quarter 6,491,911,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,748,205,000
Free Cash Flow Per Share Twelve Trailing Months 12.05
Free Cash Flow Past Year 1,661,723,000
Free Cash Flow Prior Year 1,286,404,000

Options

Put/Call Ratio 3.58
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 5.43
MACD Signal 3.93
20-Day Bollinger Lower Band 183.29
20-Day Bollinger Middle Band 207.32
20-Day Bollinger Upper Band 231.36
Beta 0.75
RSI 62.81
50-Day SMA 235.36
150-Day SMA 219.82
200-Day SMA 215.78

System

Modified 8/13/2026 7:05:44 AM EST